newsfilter
← Latest News
GlobeNewswire·

Vallon Pharmaceuticals to Participate at the 5th Annual Neuroscience Innovation Forum

David Baker, President and CEO of Vallon to participate in the virtual Advances in Neuropsychiatry Panel, today, March 23rd at 9:00 AM ET Philadelphia, PA, March 23, 2022 (GLOBE NEWSWIRE) -- Vallon Pharmaceuticals, Inc. (NASDAQ:VLON), ("Vallon"